Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 267 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

NCT06823167

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • City Of Hope Duarte, California, United States
  • University of California Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale University Medical Center New Haven, Connecticut, United States
View all 22 locations
View Trial Details
Recruiting

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

NCT07359859

Conditions
Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancies, +5 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT07216443

Conditions
Acute Disease, Bone Marrow Diseases, Disease, +24 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • Weill Cornell Medicine - New York Presbyterian Hospital New York, United States
View Trial Details
Recruiting

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT04634552

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 78 locations
View Trial Details
Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

NCT01351545

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Anemia, +43 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Mayo Clinic Arizona (adults) Phoenix, Arizona, United States
View all 142 locations
View Trial Details
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 745 locations
View Trial Details
Recruiting

DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol

NCT05722886

Conditions
Haematological Malignancy, Hematologic Diseases, Hematologic Neoplasms, +9 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details

Related conditions